4//SEC Filing
Ovid Therapeutics Inc. 4
Accession 0001209191-17-031370
$OVIDCIK 0001636651operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:13 PM ET
Size
5.5 KB
Accession
0001209191-17-031370
Insider Transaction Report
Form 4
Daly Timothy
VP, Finance & Corp. Controller
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-05-10+46,510→ 46,510 totalExercise: $8.50From: 2017-05-10Exp: 2027-01-19→ Common Stock (46,510 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001636651
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:13 PM ET
- Size
- 5.5 KB